NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMSW CUSIP: N62509117 Class: *W EXP 99/99/999

Frazier Life Sciences Management, L.P.'s Holding History (CIK: 0001892134)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 500,333 Value ($000) $11,508 Avg Close Range
Q3 2025
Shares 500,333 Value ($000) $8,561 Avg Close Range
Q2 2025
Shares 500,333 Value ($000) $4,003 Avg Close Range
Q1 2025
Shares 500,333 Value ($000) $4,498 Avg Close Range
Q4 2024
Shares 500,333 Value ($000) $7,130 Avg Close Range
Q3 2024
Shares 500,333 Value ($000) $3,502 Avg Close Range
Q2 2024
Shares 500,333 Value ($000) $4,363 Avg Close Range
Q1 2024
Shares 500,333 Value ($000) $5,524 Avg Close Range
Q4 2023
Shares 500,333 Value ($000) $1,566 Avg Close Range
Q3 2023
Shares 500,333 Value ($000) $951 Avg Close Range
Q2 2023
Shares 500,333 Value ($000) $1,046 Avg Close Range
Q1 2023
Shares 500,333 Value ($000) $921 Avg Close Range
Q4 2022
Shares 500,333 Value ($000) $434 Avg Close Range